Discover relevant content from across the suite of ALM legal publications
From the Industry
More content from ThinkAdvisor and select sponsors
Investment Advisor Issue Gallery
Read digital editions of Investment Advisor Magazine
Tax Facts
Get clear, current, and reliable answers to pressing tax questions
Copyright © 2024 ALM Global, LLC. All Rights Reserved.
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
A deep dive into how advisors can best serve the evolving needs of their wealthiest clients
Tax Facts
Anticipate your clients' tax questions on Social Security, annuities and a range of investment products
Popular Financial Topics
Go deeper on emerging topics, as well as key firms and thought leaders
November 18, 2015 at 06:08 AM
(Bloomberg) — The world’s annual pharmaceutical bill will grow by about a third to $1.4 trillion in 2020 as brand-name drugs for cancers and rare diseases come to market, according to researchers at the IMS Institute for Healthcare Informatics.
Among the report’s top findings:
So-called specialty therapies will dominate spending, with oncology treatments totaling $110 billion, followed by autoimmune drugs. Treatments for viral hepatitis, including Gilead Science Inc.’s hepatitis C drugs Sovaldi and Harvoni along with AbbVie Inc.’s Viekira Pak, will make up $48 billion.
The United States will spend the most on drugs, with 41 percent of the global bill. China will spend $150 billion to $180 billion in 2020, representing a 6 percent to 9 percent compound annual growth rate. The global growth rate is 4 percent to 7 percent.
IMS estimates 225 new treatments will be introduced in the next five years. Of these, drugs for rare diseases and cancers will dominate.
See also: Goldman Sachs: Health care costs are about to start pushing core inflation higher
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Copyright © 2024 ALM Global, LLC. All Rights Reserved.
Podcast Center
Video Center
Webcasts
Resource Center
Events
